Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» biosimilars
biosimilars
Spinoff updates: Merck’s Organon and Novartis’ Sandoz
Generics and Biosimilar Initiative
Mon, 11/29/21 - 11:08 pm
spinoffs
Merck
Organon
earnings
Novartis
Sandoz
biosimilars
Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead
Fierce Pharma
Mon, 11/22/21 - 10:13 pm
Amgen
biosimilars
Otezla
Repatha
Viatris launched two versions of its interchangeable insulin biosimilar. Why?
Fierce Pharma
Tue, 11/16/21 - 10:29 pm
Biocon
Viatris
Semglee
insulin
biosimilars
diabetes
Sanofi
Lantus
Boehringer's interchangeable tag for Humira biosim is a 'landmark' win for the field: analyst
Fierce Pharma
Tue, 10/19/21 - 11:59 am
Boehringer Ingelheim
Humira
biosimilars
interchangeable biosimilars
Cyltezo
AbbVie
patents
Boehringer wins 'interchangeable' status for Humira copy, strengthening competitive threat
BioPharma Dive
Mon, 10/18/21 - 10:55 pm
Boehringer Ingelheim
AbbVie
Humira
interchangeable biosimilars
biosimilars
Cyltezo
FDA
Alvotech scores in AbbVie trade secrets case, but the Humira patent fight will stretch into next year
Fierce Pharma
Fri, 10/8/21 - 10:32 am
Alvotech
AbbVie
patents
Humira
trade secrets
biosimilars
Physicians hesitant to switch patients from biologics to biosimilar drugs, report finds
Beckers Hospital Review
Mon, 09/27/21 - 10:55 am
biologics
biosimilars
physicians
Biosimilar drugs gain ground in U.S., but concerns linger about when patients can switch
Stat
Tue, 09/21/21 - 10:45 am
biosimilars
patients
FDA finalizes more Q&As on biosimilar development
RAPS.org
Mon, 09/20/21 - 11:03 pm
FDA
regulatory
biosimilars
drug development
FDA approves first biosimilar to top-selling eye drug Lucentis
BioPharma Dive
Mon, 09/20/21 - 10:55 pm
FDA
biosimilars
Lucentis
age-related macular degeneration
Byooviz
Biogen
Samsung Bioepis
Sandoz in oncology biosimilar deal with China’s Bio-Thera
Biopharma Reporter
Wed, 09/8/21 - 11:15 am
Sandoz
Novartis
biosimilars
China
BAT1706
Bio-Thera Solutions
Pharmacist-driven biosimilar substitution saves money
GaBI
Sat, 08/28/21 - 09:08 pm
biosimilars
generics
pharmacists
ASCO
Biosimilars versus biologics: Is marketing madness on the way as biosimilar approvals balloon?
Fierce Pharma
Tue, 08/17/21 - 10:13 am
biosimilars
biologics
DTC ads
J&J, Amgen and Roche face growing biosimilar competition that is driving down prices: report
Fierce Pharma
Thu, 08/12/21 - 11:04 pm
JNJ
Amgen
Roche
biosimilars
drug pricing
PhRMA calls for FDA to address unique needs of biosimilar review program
Biopharma Reporter
Mon, 08/9/21 - 10:59 am
PhRMA
FDA
capacity planning adjustment
biosimilars
How This Historic FDA Approval Benefits Viatris
Motley Fool
Wed, 08/4/21 - 10:57 am
Viatris
Biocon
FDA
Semglee
biosimilars
insulin
diabetes
interchangeable biosimilars
FDA approves first interchangeable biosimilar
Biopharma Reporter
Thu, 07/29/21 - 11:19 am
FDA
biosimilars
interchangeable biosimilars
Semglee
Viatris
diabetes
insulin
Lantus
Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms
Fierce Pharma
Mon, 07/26/21 - 10:14 pm
Pfizer
JNJ
Remicade
biosimilars
legal
Cost-cutting generics and biosimilars stuck in legal limbo
MedCity News
Thu, 07/22/21 - 10:58 am
generics
biosimilars
drug pricing
patents
Fear not, AbbVie. Sales king Humira might have a graceful fall from biosim attack: analyst
Fierce Pharma
Tue, 07/13/21 - 11:02 am
AbbVie
Humira
patents
biosimilars
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »